These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4162844)

  • 21. [Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
    Mirone V; Prezioso D; Palmieri A; Bocchini P
    Minerva Urol Nefrol; 1988; 40(2 Suppl):16-7. PubMed ID: 2460938
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is there a hormonal etiology in prostatic hypertrophy?].
    Robel P
    Ann Urol (Paris); 1985; 19(3):151-2. PubMed ID: 2411205
    [No Abstract]   [Full Text] [Related]  

  • 23. From the history of prostatic hypertrophy. A medico-historical investigation of its pathology and palliative surgical treatment up to the beginning of the 20th century. Appendix: from the history of lithotomy. A short survey of the development of the different methods.
    Lauridsen L
    Dan Med Bull; 1969 Mar; 16(3):77-82. PubMed ID: 4190167
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hormone therapy of prostate adenoma & carcinoma].
    ALKEN CE; BUSCHER HK
    Munch Med Wochenschr; 1957 Jun; 99(24):872-7. PubMed ID: 13451563
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the evaluation and treatment of benign prostatic hypertrophy].
    Wabrosch G; Vanik M
    Orv Hetil; 1993 Oct; 134(44):2411-6. PubMed ID: 7694220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormonal therapy of benign prostatic hyperplasia].
    Horninger W; Bartsch G
    Urologe A; 1995 Jan; 34(1):9-15. PubMed ID: 7533450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transurethral non-contact laser treatment of prostatic hypertrophy].
    Zhao SD; Xue J; Xu XM
    Zhonghua Wai Ke Za Zhi; 1994 Apr; 32(4):246-8. PubMed ID: 7531136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [So-called spontaneous prostatic hypertrophy in dogs and experimental hypertrophy induced by estrogens and androgens with reference to histo-enzymologic behavior].
    Mincione G; Borri M; Romeo A
    Arch De Vecchi Anat Patol; 1965 Aug; 45(2):465-96. PubMed ID: 4160509
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complication of adenomectomy of the prostate and methods of their treatment].
    Lopatkin NA
    Urol Nefrol (Mosk); 1982; (1):3-9. PubMed ID: 6176058
    [No Abstract]   [Full Text] [Related]  

  • 31. [The intraurethral catheter. A 3-year experience].
    Nissenkorn I
    J Urol (Paris); 1993; 99(6):321-3. PubMed ID: 7516379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Giant prostatic hypertrophy: a case report].
    Yonou H; Goya M; Miyazato M; Sugaya K; Hatano T; Ogawa Y
    Hinyokika Kiyo; 1999 May; 45(5):375-7. PubMed ID: 10410325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Finasteride. A new 5 alpha reductase inhibitor registered for treatment of benign prostatic hypertrophy with the purpose of avoiding or postponing surgery].
    Hansen BJ; Hvidt V
    Ugeskr Laeger; 1993 Dec; 155(50):4110-2. PubMed ID: 7505966
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prostatic adenomectomy with preliminary suturing of the adenoma capsule].
    Gorilovskiĭ LM; Veligura VI; Viazenkin SM; Modorskiĭ MI; Titova VM
    Urol Nefrol (Mosk); 1981; (4):34-9. PubMed ID: 6168086
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of prostatic hypertrophy with depostat].
    Nuri M; Hochberg K
    Munch Med Wochenschr; 1970 May; 112(22):1057-60. PubMed ID: 4192989
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
    Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
    Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of benign prostatic hypertrophy].
    Romics I
    Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
    [No Abstract]   [Full Text] [Related]  

  • 38. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique.
    Goya N; Ishikawa N; Ito F; Ryoji O; Tokumoto T; Toma H; Yamaguchi Y
    J Urol; 1999 Aug; 162(2):383-6. PubMed ID: 10411043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Doxazosin in the treatment of benign prostatic hypertrophy].
    Rollema HJ; Janknegt RA
    J Urol (Paris); 1993; 99(6):314-5. PubMed ID: 7516377
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transurethral resection and transvesical prostatectomy in the treatment of prostatic hypertrophy].
    Mortensen T; Ellekilde G
    Ugeskr Laeger; 1980 Aug; 142(35):2261-4. PubMed ID: 6158776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.